In this episode of Pathology News Talks, we sit down with Andy Beck, Co-Founder and CEO of PathAI, to explore the transformation of pathology through artificial intelligence.

Andy shares his journey from academia to building one of the most influential companies in digital pathology, reflects on the challenges of regulation and adoption, and discusses PathAI’s recent FDA clearance for its AISight DX platform. We also dive into collaborations with Roche and leading medical centres, the rise of digital biomarkers, and what the future of AI-powered pathology might look like in the next decade.

If you want to understand how digital pathology, AI, and clinical workflows are converging to shape the future of diagnostics, this episode is for you.